Newsroom | 3047 results

WATERTOWN, Mass.--(BUSINESS WIRE)--Ingenia Therapeutics, a clinical-stage biotechnology company pioneering next-generation vascular-targeted therapies, announced that the company has received approval from the KRX to proceed with its Initial Public Offering (IPO). The move marks a pivotal transition for the company, supported by a robust pipeline that includes two clinical-stage assets, one of which is IGT-427 (now called MK-8748), an investigational bi-specific antibody (Anti-VEGF/TIE2), for p...

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that management will participate in the following upcoming conferences: Stifel 2026 Virtual Ophthalmology Forum Date: Tuesday, May 26, 2026 Format: Meetings and Webcast Fireside Chat Details: Investor meeting participation is by invitation only from the sponsoring brokerage firm. Webcas...

BOSTON--(BUSINESS WIRE)--Ontada®, a business for oncology insights, announced the inclusion of Florida Cancer Specialists & Research Institute's data into its ecosystem....

INCHEON, Korea--(BUSINESS WIRE)--Samsung Bioepis announced the launch of Ustekinumab BS 45 mg Syringe for S.C. Injection「 NIPRO」 in Japan....

DURHAM, N.C.--(BUSINESS WIRE)--Lexitas Pharma Services, a portfolio company of QHP Capital, is pleased to announce the closing of its acquisition of Erie Retina Research—one of the nation’s premier retina research centers led by Dr. David Almeida, MD, MBA, PhD—which will operate as a wholly owned subsidiary of Lexitas. As part of the transaction, Lexitas also acquired CASExERIE, LLC, an ophthalmic innovation hub specializing in advanced research, surgical training, and retina-focused product de...

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of PreserVision AREDS3 eye vitamins, which combine the clinically proven AREDS2 nutrients recommended by the NEI to help reduce the risk of moderate-to-advanced AMD progression with a unique B-vitamin complex.* Built on decades of leadership in AREDS-based vitamins, PreserVision AREDS3 is the mos...

LUGANO, Switzerland--(BUSINESS WIRE)--SERI Lugano Launches International Scientific Outreach Initiative on Light-Based Neuroscience and Pineal Gland Research...

BONITA SPRINGS, Fla.--(BUSINESS WIRE)--Optivate, a leading provider of specialty-built software and solutions for ophthalmology practices, today announced the appointment of Brad Caldwell as Chief Executive Officer. Abdiel Marin, the company’s Founder and CEO, will transition to a role as an advisor and remain on the Board of Directors as the company enters its next phase of growth. Caldwell brings extensive experience in healthcare technology, go-to-market strategy, and operational leadership....

BOSTON & PHILADELPHIA--(BUSINESS WIRE)--Ontada, a McKesson business dedicated to real-world oncology data and insights, will present new research and introduce ON.Journey at ISPOR 2026....

IRVINE, Calif.--(BUSINESS WIRE)--SBC Medical announce to first quarter financial results...